Uniunea Europeană - română - EMA (European Medicines Agency)

ucb pharma sa - certolizumab pegol - crohn boala - imunosupresoare - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. cimzia poate fi administrat în monoterapie în caz de intoleranță la metotrexat sau atunci când tratamentul continuu cu metotrexat este inadecvat. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.